These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 20518512)
1. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512 [TBL] [Abstract][Full Text] [Related]
2. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. Etrych T; Jelínková M; Ríhová B; Ulbrich K J Control Release; 2001 May; 73(1):89-102. PubMed ID: 11337062 [TBL] [Abstract][Full Text] [Related]
3. HPMA copolymer-based polymer conjugates for the delivery and controlled release of retinoids. Lidický O; Šírová M; Etrych T Physiol Res; 2016 Oct; 65(Suppl 2):S233-S241. PubMed ID: 27762589 [TBL] [Abstract][Full Text] [Related]
4. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect. Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257 [TBL] [Abstract][Full Text] [Related]
5. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel. Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304 [TBL] [Abstract][Full Text] [Related]
6. Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification. Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Ríhová B; Ulbrich K J Control Release; 2006 Sep; 115(1):26-36. PubMed ID: 16899320 [TBL] [Abstract][Full Text] [Related]
7. HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity. Ulbrich K; Etrych T; Chytil P; Jelínková M; Ríhová B J Control Release; 2003 Feb; 87(1-3):33-47. PubMed ID: 12618021 [TBL] [Abstract][Full Text] [Related]
8. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity. Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282 [TBL] [Abstract][Full Text] [Related]
9. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin. Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482 [TBL] [Abstract][Full Text] [Related]
10. HPMA-based polymer conjugates with drug combination. Krakovicová H; Etrych T; Ulbrich K Eur J Pharm Sci; 2009 Jun; 37(3-4):405-12. PubMed ID: 19491032 [TBL] [Abstract][Full Text] [Related]
11. Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release. Chytil P; Šírová M; Kudláčová J; Říhová B; Ulbrich K; Etrych T Mol Pharm; 2018 Sep; 15(9):3654-3663. PubMed ID: 29543465 [TBL] [Abstract][Full Text] [Related]
12. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy. Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933 [TBL] [Abstract][Full Text] [Related]
13. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics. Vicent MJ; Manzanaro S; de la Fuente JA; Duncan R J Drug Target; 2004; 12(8):503-15. PubMed ID: 15621676 [TBL] [Abstract][Full Text] [Related]
14. Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specific membrane antigen expressing prostate cancer. Peng ZH; Sima M; Salama ME; Kopečková P; Kopeček J J Drug Target; 2013 Dec; 21(10):968-80. PubMed ID: 24160903 [TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic antitumor activity of HPMA copolymer-paclitaxel-alendronate conjugate on breast cancer bone metastasis mouse model. Miller K; Eldar-Boock A; Polyak D; Segal E; Benayoun L; Shaked Y; Satchi-Fainaro R Mol Pharm; 2011 Aug; 8(4):1052-62. PubMed ID: 21545170 [TBL] [Abstract][Full Text] [Related]
16. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies. Li L; Zhou M; Huang Y Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570 [TBL] [Abstract][Full Text] [Related]
17. Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation. Ulbrich K; Etrych T; Chytil P; Jelínková M; Ríhová B J Drug Target; 2004; 12(8):477-89. PubMed ID: 15621674 [TBL] [Abstract][Full Text] [Related]
18. Polymeric nanotheranostics for real-time non-invasive optical imaging of breast cancer progression and drug release. Ferber S; Baabur-Cohen H; Blau R; Epshtein Y; Kisin-Finfer E; Redy O; Shabat D; Satchi-Fainaro R Cancer Lett; 2014 Sep; 352(1):81-9. PubMed ID: 24614283 [TBL] [Abstract][Full Text] [Related]
19. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles. Zhou Z; Li L; Yang Y; Xu X; Huang Y Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427 [TBL] [Abstract][Full Text] [Related]
20. Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates. Lidický O; Janoušková O; Strohalm J; Alam M; Klener P; Etrych T Molecules; 2015 Nov; 20(11):19849-64. PubMed ID: 26556320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]